A questionnaire survey to explore the current treatment policies adopted for patients with advanced hepatocellular carcinoma at board‐certified <scp>HPB</scp> training institutions in Japan: A <scp>JSHBPS</scp> project study 2023, Part 1
The present survey clarified the current clinical approaches for the treatment of advanced HCC at HPB training centers. Future analysis, including survival outcomes, would offer important insights into the optimal management of advanced HCC.
Authors
- Takuma Okada
- Masaru Matsumura (ORCID: https://orcid.org/0000-0001-7898-7595)
- S. Okubo (ORCID: https://orcid.org/0000-0001-8235-5603)
- Masafumi Nakamura (ORCID: https://orcid.org/0000-0002-6196-8643)
- Masaji Hashimoto (ORCID: https://orcid.org/0000-0003-0616-3348)
- Masayuki Ohtsuka (ORCID: https://orcid.org/0000-0002-5091-1078)
Institutions
- Okinaka Memorial Adult Disease Research Institute (JP)
- Japan Pancreatic Disease Research Foundation (JP)
- Toranomon Hospital (JP)
- Okinaka Memorial Institute for Medical Research
Publication Details
- Journal
- Journal of Hepato-Biliary-Pancreatic Sciences
- Published
- 2025-03-16
- DOI
- https://doi.org/10.1002/jhbp.12139
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32